Conte aos seus amigos sobre este item:
Drugs for HER-2-positive Breast Cancer - Milestones in Drug Therapy Maria Sibilia
Drugs for HER-2-positive Breast Cancer - Milestones in Drug Therapy
Maria Sibilia
Growth factor receptors have long been known to drive malignant transformation and cancer progression. The epidermal growth factor receptor (EGFR, ErbB, HER) system is likely the best described membrane receptor tyrosine kinase family in malignant tumors.
120 pages, biography
| Mídia | Livros Hardcover Book (Livro com lombada e capa dura) |
| Lançado | 7 de janeiro de 2011 |
| ISBN13 | 9783034600934 |
| Editoras | Birkhauser Verlag AG |
| Páginas | 110 |
| Dimensões | 164 × 244 × 14 mm · 299 g |
| Idioma | Francês |
| Editor | Bartsch, Rupert |
| Editor | Grunt, Thomas W. |
| Editor | Sibilia, Maria |
| Editor | Zielinski, Christoph C. |